BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• 

  Rare diseases

  Sanofi cans late-stage study for rare autoimmune disease on underwhelming efficacy

  The discontinuation of Sanofi’s Phase 3 study for its complement inhibitor drug in chronic inflammatory demyelinating polyneuropathy delivers an ‘obviously disappointing’ blow to the broader drug class, according to William Blair.

  June 10, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial

  June 10, 2026

   · 

  7 min read
• Press Releases

  Urteste S.A. enrolls the first patient in the Panuri test clinical study

  June 10, 2026

   · 

  3 min read
• Press Releases

  Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.

  June 10, 2026

   · 

  11 min read
• Press Releases

  Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology

  June 10, 2026

   · 

  3 min read
• Press Releases

  Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

  June 10, 2026

   · 

  9 min read
• Press Releases

  JenaValve Appoints Matt Bacso as Chief Financial Officer

  June 10, 2026

   · 

  4 min read
• Press Releases

  AbTherx Expands Platform and Leadership Team to Unlock Antibody Discovery for Multispecifics, Enzymes, GPCRs, and Ion Channels

  June 10, 2026

   · 

  4 min read
• Press Releases

  Cytovance Biologics Launches In-House Cell Line Development with High-Yield Titers up to 10g/L

  June 10, 2026

   · 

  2 min read
• Press Releases

  Cellares Joins New American Industrial Alliance, Advancing U.S. Biopharmaceutical Manufacturing Independence

  June 10, 2026

   · 

  5 min read